Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-015629)

Filing Details

Accession Number:: 0001209191-19-015629
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-04 16:26:59
Reporting Period:: 2019-02-28

Accepted Time:: 2019-03-04 16:26:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1427925	Acelrx Pharmaceuticals Inc	ACRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310803	N Badri Dasu	C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063	Chief Engineering Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-28	9,206	$2.81	113,267	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Balance includes non-reportable acquisition of 9,206 shares of Common Stock through the Company's Employee Stock Purchase Plan.